Navigation Links
Salmonella survives better in stomach due to altered DNA

nd survive better and are therefore more infectious: the evolution of a pathogen. Examining which genetic characteristics are present in an infectious Salmonella (in this case the DT104 type) can reveal how this pathogen has become stronger and caused more outbreaks. This information can also be used to make a less dangerous variant of this infectious Salmonella. Such a harmless variant can be used as a vaccine.

Salmonella serovar Typhimurium DT104 is an antibiotic-resistant pathogen that is transmitted via food and is considered to be dangerous for humans. In recent decades the number of infections with this variant has increased in many parts of the world. This research was funded by NWO and contributes to knowledge about the characteristics and behaviour of this dangerous Salmonella.
'"/>

Source:Netherlands Organization for Scientific Research


Page: 1 2

Related biology news :

1. Salmonella caught red-handed
2. Salmonella bacteria use RNA to assess and adjust magnesium levels
3. Scientists reveal how disease bacterium survives inside immune system cell
4. Chemists create Superbowl molecule; May lead to better health
5. Protein discovery could unlock the secret to better TB treatment
6. Signaling protein builds bigger, better bones in mice
7. Harnessing microbes, one by one, to build a better nanoworld
8. Two are better than one
9. Discovery may lead to better Candidiasis drug
10. Insects, viruses could hold key for better human teamwork in disasters
11. Atmosphere may cleanse itself better than previously thought
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Salmonella survives better stomach due altered DNA

(Date:5/11/2015)... Calif. , May 11, 2015  Synaptics ... of human interface solutions, today announced the appointment ... President and Chief Financial Officer, reporting to ... replaces Synaptics, current Chief Financial Officer, Kathleen ... 2014. Mr. Ali brings extensive ...
(Date:5/11/2015)... -- Curemark LLC, a privately held drug research and ... III double blind, randomized, placebo-controlled clinical trial to examine ... children ages 3-8 with Autism. Previously, Curemark announced the ... clinical trial for CM-AT in children ages 3-8 with ... chymotrypsin. This new trial will help determine whether all ...
(Date:5/8/2015)... -- Synaptics Inc. (NASDAQ: SYNA ), the leading developer ... executive management team will present at the following investor events: ... Conference Date: May 18, 2015 Time: 10:40am ET ... Cowen and Company Technology, Media & Telecom ... New York Palace Hotel, New York, NY ...
Breaking Biology News(10 mins):Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2Synaptics to Present at Upcoming Investor Conferences 2
... the globe came together at Rensselaer Polytechnic Institute Nov. ... Energy Research to discuss the development of technologies that ... on Earth: photosynthesis. The conference, titled "At the Interface ... Lakshmi, assistant professor of chemistry and chemical biology and ...
... and depth of the Deepwater Horizon oil spill ... severity of ecological damage and to develop restoration plans for ... report by the National Research Council. A broad approach ... production -- in addition to replacing natural resources damaged by ...
... each to put towards developing technologies such as instrumentation, ... genomics research. "We received over 40 ... imaginative research ideas," commented Dr. Mark Poznansky, President and ... Ontario,s researchers and their work that might not be ...
Cached Biology News:Solar Energy Research Conference at Rensselaer draws solar experts from around the world 2Solar Energy Research Conference at Rensselaer draws solar experts from around the world 3New report offers broad approach to assessing impacts of ecological damage 2New report offers broad approach to assessing impacts of ecological damage 3200 thousand dollars awarded to genomics researchers to spark new research technology development 2200 thousand dollars awarded to genomics researchers to spark new research technology development 3
(Date:5/27/2015)... May 27, 2015 RXi Pharmaceuticals Corporation ... on discovering and developing innovative therapies primarily in ... it has commenced a public offering of shares ... of its common stock and overallotment purchase rights ... shares of common stock, warrants and overallotment purchase ...
(Date:5/27/2015)... , May 26, 2015 Research and ... the "Global Breast Cancer Monoclonal Antibodies Market ... Globally, Roche seems to dominate the breast ... Its block buster molecule, Herceptin has been able ... was found that breast cancer cells become recalcitrant ...
(Date:5/27/2015)... 27, 2015 Expanding in a big ... Avalon Biomed Inc. recently inked a deal ... Dental Co. Ltd. , the largest endodontic distributor in ... international market for Avalon Biomed, which manufactures Grey MTA ... silicate-based dental cements that have won renown from dentists ...
(Date:5/27/2015)... , May 27, 2015  Tikcro Technologies Ltd. (OTCQB: ... March 31, 2015. Aviv Boim ... continued pre-clinical work to generate functional specific antibodies, targeting ... stage, we are encouraged by the development progress. We ... new antibodies which modulate immune checkpoints gain clinical acceptance ...
Breaking Biology Technology:RXi Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants 2RXi Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants 3Global Breast Cancer Monoclonal Antibodies Market Outlook 2020 2Global Breast Cancer Monoclonal Antibodies Market Outlook 2020 3Dental Manufacturer Avalon Biomed Inks Major Deal with Japanese Distributor 2Dental Manufacturer Avalon Biomed Inks Major Deal with Japanese Distributor 3Tikcro Technologies Reports First Quarter 2015 Results 2Tikcro Technologies Reports First Quarter 2015 Results 3
... never heard of "graphene" before, you might know something about ... announcements. Two physicists at the University of Manchester (UK) ... regarding the two-dimensional material graphene," carbon flakes that are only ... steel and as conductive as copper. But, what happens ...
... for medicine awarded to Robert Edwards, the pioneer British biologist ... doubts about the importance of ,test tube babies, that have ... put to rest," says Michael S. Opsahl, M.D., ... Magazine. "IVF, once perceived as expensive and a ...
... Enerkem Named A Top Global Cleantech Company ... ... ... are keyed by longUrl, so we need to grab the first one. for (var r in data.results) ...
Cached Biology Technology:Beyond the Nobel Prize, what's next for graphene? 2Nobel Spotlight on IVF Boosts Family Building Procedures 2Enerkem Named A Top Global Cleantech Company 2Enerkem Named A Top Global Cleantech Company 3Enerkem Named A Top Global Cleantech Company 4Enerkem Named A Top Global Cleantech Company 5Enerkem Named A Top Global Cleantech Company 6Enerkem Named A Top Global Cleantech Company 7
For testing the AQUA technique on your MS instruments....
0.2ml Gradient Block MBSR. Robot compatible block ejection mechanism. Stackable. (96 well block - holds 1 plate 0.2ml x 96 well plate)...
Our original highly-purified, robust Taq Polymerase which delivers consistently high yields and minimal background...
A Highly Purified, Cost-Effective Taq DNA Polymerase...
Biology Products: